Alpha interferon administration to infants with congenital rubella.

Three infants with congenital rubella syndrome were given human leukocyte (alpha) interferon at doses of 2 x 10(5) to 7 X 10(5) U/kg per day for 10 days. A transient decrease in pharyngeal virus excretion was observed with treatment. No significant side effects were associated with the administratio...

Celý popis

Podrobná bibliografie

Vydáno v:	Antimicrob Agents Chemother
Hlavní autoři:	Arvin, A M, Schmidt, N J, Cantell, K, Merigan, T C
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	American Society for Microbiology (ASM) 1982
Témata:	Research Article
On-line přístup:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC181869/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/6176183/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.21.2.259
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!